Endocytic mechanism of transferrin-conjugated nanoparticles and the effects of their size and ligand number on the efficiency of drug delivery

Journal of Electron Microscopy

Volumn 62, Issue 3, 2013, Pages 341-352

  Tsuji, Takuma ^a   Yoshitomi, Hiroshi ^a   Usukura, Jiro ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

clathrin; drug delivery; nanoparticles; poly(lactic co glycolic acid); transferrin; transferrin receptor

Indexed keywords

CLATHRIN; DOXORUBICIN; DRUG CARRIER; LACTIC ACID; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ARTICLE; CELL SURVIVAL; COATED VESICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENDOCYTOSIS; HELA CELL; HUMAN; METABOLISM; NEOPLASM; PARTICLE SIZE; POLY(LACTIC-CO-GLYCOLIC ACID); TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

CLATHRIN; DRUG DELIVERY; NANOPARTICLES; POLY(LACTIC-CO-GLYCOLIC ACID); TRANSFERRIN; TRANSFERRIN RECEPTOR;

CELL LINE, TUMOR; CELL SURVIVAL; CLATHRIN-COATED VESICLES; DOXORUBICIN; DRUG CARRIERS; ENDOCYTOSIS; HELA CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LACTIC ACID; NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; POLYGLYCOLIC ACID; TRANSFERRIN;

ANTIGEN-ANTIBODY REACTIONS; CANCER CELLS; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DISEASES; MOLECULAR BIOLOGY; MOLECULES; TARGETED DRUG DELIVERY;

CANCER CELLS; CELL-BE; CELL/B.E; CLATHRIN-COATED VESICLES; CLATHRINS; POLY LACTIC-CO-GLYCOLIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); TRANSFERRIN; TRANSFERRIN RECEPTORS;

NANOPARTICLES;

EID: 84879147391     PISSN: 00220744     EISSN: 14779986     Source Type: Journal    
DOI: 10.1093/jmicro/dfs080     Document Type: Article

References (35)

1. Qian Z M, Li H, Sun H, and Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54: 561-587
2. Sudimack J and Lee R J (2000) Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41: 147-162
3. Ryschich E, Huszty G, Knaebel H P, Hartel M, Buchler M W, and Schmidt J (2004) Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur. J. Cancer 40: 1418-1422
4. Wagner E, Curial D, and Cotton M (1994) Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptormediated endocytosis. Adv. Drug Deliv. Rev. 14: 113-135
5. Pearse B M F (1982) Coated vesicles from human placenta carry ferritin, transferrin, and immunoglobulin G. Proc. Natl Acad. Sci. USA 79: 451-455
6. Sun X, Yau V K, Briggs B J, and Whittaker G R (2005) Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Viology 338: 53-60
7. Win K Y and Feng S S (2005) Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26: 2713-2722
8. Veiga E and Cossart P (2005) Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat. Cell Biol. 7: 894-900
9. Cureton D K, Massol R H, Saffarian S, Kirchhausen T L, and Whelan S P J (2009) Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog. 5: E1000394
10. Moreno-Ruiz E, Galan-Diez M, Zhu, Fernandez-Ruiz E, d'Enfert C, Filler S G, Cossart P, and Veiga E (2009) Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell. Microbiol. 11: 1179-1189
11. Aggeler J and Werb Z (1982) Initial events during phagocytosis by macrophages viewed from outside and inside the cell: Membraneparticle interactions and clathrin. J. Cell. Biol. 94: 613-623
12. Usukura J and Bok D (1987) Changes in the localization and content of opsin during retinal development in the rds mutant mouse: Immunocytochemistry and immunoassay. Exp. Eye Res. 45: 501-515
13. Heuser J (2000) The production of 'cell cortices' for light and electron microscopy. Traffic 1: 545-552
14. Morone N, Fujiwara T, Murase K, Kasai R S, Ike H, Yuasa S, Usukura J, and Kusumi A (2006) Three-dimensional reconstruction of the membrane skeleton at the plasma membrane interface by electron tomography. J. Cell Biol. 174: 851-862
15. Bilati U, Allemann E, and Doelker E (2005) Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sci. 24: 67-75
16. Mu L and Feng S S (2003) A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release 86: 33-48
17. Yoo H S, Lee K H, Oh J E, and Park T G (2000) In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J. Control. Release 68: 419-431
18. Chen G, Sato T, Tanaka J, and Tateishi T (2006) Preparation of a biphasic scaffold for osteochondral tissue engineering. Mater. Sci. Eng. C 26: 118-123
19. He C, Hu Y, Yin L, Tang C, and Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31: 3657-3666
20. Pang Z, Gao H, Yu Y, Guo L, Chen J, Pan S, Ren J, Wen Z, and Jiang X (2011) Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin. Bioconjugate. Chem. 22: 1171-1180
21. Sahoo S K and Labhasetwar V (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharmaceutics 2: 373-383
22. Gan C W and Feng S S (2010) Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood brain barrier. Biomaterials 31: 7748-7757
23. Eavarone D A, Yu X, and Bellamkonda R V (2000) Targeted drug delivery to C6 glioma by transferrin-coupled liposomes. J. Biomed. Mater. Res. 51: 10-14
24. Maeda H, Wu J, Sawa T, Matsumura Y, and Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J. Control. Release 65: 271-284
25. Nagayasu A, Uchiyama K, and Kiwada H (1997) The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40: 75-87
26. Chithrani B D and Chan W C W (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7: 1542-1550
27. ter Haar E, Musacchio A, Harrison S C, and Kirchhausen T (1998) Atomic structure of clathrin: A β propeller terminal domain joins an α zigzag linker. Cell 95: 563-573
28. Piehl M, Lehmann C, Gumpert A, Denizot J P, Segretain D, and Falk M M (2007) Internalization of large double-membrane intercellular vesicles by a clathrin-dependent endocytic process. Mol. Biol. Cell 18: 337-347
29. Veiga E, Guttman J A, Bonazzi M, Boucrot E, Toledo-Arana A, Lin A E, Enninga J, Cerda J P, Finlay B B, Kirchhausen T, and Cossart P (2007) Invasive and adherent bacterial pathogens co-Opt host clathrin for infection. Cell Host Microbe 2: 340-351
30. Astete C E and Sabliov C M (2006) Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci. Polymer Edn. 17: 247-289
31. Lao B J, Tsai W L P, Mashayekhi F, Pham E A, Mason A B, and Kamei D T (2007) Inhibition of transferrin iron release increases in vitro drug carrier efficacy. J. Control Release 117: 403-412
32. Lin R, Ng L S, and Wang C H (2005) In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 26: 4476-4485
33. Xu Q, Liu Y, Su S, Li W, Chen C, and Wu Y (2012) Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 33: 1627-1639
34. Shah N, Chaudhari K, Dauntuluri P, Murthy R S R, and Das S (2009) Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic®P85, an in vitro cell line and in vivo biodistribution studies on rat model. J. Drug Target. 17: 533-542
35. Prabha S, Zhou W Z, Panyam J, and Labhasetwar V (2002) Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int. J. Pharm. 244: 105-115